CHI3L1 and Alzheimer disease: Interestingly, plasma YKL-40 levels in patients with mild AD, but not in those with moderate or severe AD, correlated positively with cognitive assessment test results, highlighting its potential to signal the onset of cognitive symptoms of AD [105].